Medtronic plc
MDT · NYSE
10/24/2025 | 7/25/2025 | 4/30/2025 | 1/24/2025 | |
|---|---|---|---|---|
| Revenue | $9 | $9 | $9 | $8 |
| % Growth | 4.5% | -3.9% | 7.7% | – |
| Cost of Goods Sold | $4 | $4 | $3 | $3 |
| Gross Profit | $5 | $5 | $6 | $6 |
| % Margin | 60.3% | 57.7% | 64.7% | 66.5% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $1 | $0 |
| Operating Expenses | $4 | $4 | $4 | $4 |
| Operating Income | $2 | $1 | $1 | $2 |
| % Margin | 18.8% | 16.8% | 16.1% | 19.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $2 | $1 | $1 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 15.3% | 12.1% | 11.8% | 15.6% |
| EPS | 1.07 | 0.81 | 0.82 | 1.01 |
| % Growth | 32.1% | -1.2% | -18.8% | – |
| EPS Diluted | 1.07 | 0.81 | 0.82 | 1.01 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $2 | $2 | $2 | $2 |
| % Margin | 26.4% | 25.9% | 25.5% | 29% |